245 related articles for article (PubMed ID: 9591781)
41. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.
Morrison AA; Venables JP; Dellaire G; Ladomery MR
Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543
[TBL] [Abstract][Full Text] [Related]
42. Intracerebral small round cell tumor: an unusual case with EWS-WT1 translocation.
Bouchireb K; Auger N; Bhangoo R; Di Rocco F; Brousse N; Delattre O; Varlet P; Grill J
Pediatr Blood Cancer; 2008 Oct; 51(4):545-8. PubMed ID: 18561179
[TBL] [Abstract][Full Text] [Related]
43. WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein.
Wang ZY; Qiu QQ; Gurrieri M; Huang J; Deuel TF
Oncogene; 1995 Mar; 10(6):1243-7. PubMed ID: 7700651
[TBL] [Abstract][Full Text] [Related]
44. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product.
Zhang PJ; Goldblum JR; Pawel BR; Fisher C; Pasha TL; Barr FG
Mod Pathol; 2003 Mar; 16(3):229-35. PubMed ID: 12640103
[TBL] [Abstract][Full Text] [Related]
45. Variant EWS-WT1 chimeric product in the desmoplastic small round cell tumor.
Chan AS; MacNeill S; Thorner P; Squire J; Zielenska M
Pediatr Dev Pathol; 1999; 2(2):188-92. PubMed ID: 9949226
[TBL] [Abstract][Full Text] [Related]
46. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
47. Tissue-specific regulation of the WT1 locus.
Hewitt JA; Kessler PM; Campbell CE; Williams BR
Med Pediatr Oncol; 1996 Nov; 27(5):456-61. PubMed ID: 8827074
[TBL] [Abstract][Full Text] [Related]
48. Chromosome translocation-mediated conversion of a tumor suppressor gene into a dominant oncogene: fusion of EWS1 to WT1 in desmoplastic small round cell tumors.
Rauscher FJ
Curr Top Microbiol Immunol; 1997; 220():151-62. PubMed ID: 9103681
[No Abstract] [Full Text] [Related]
49. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy.
Kaneko Y; Yoshida K; Handa M; Toyoda Y; Nishihira H; Tanaka Y; Sasaki Y; Ishida S; Higashino F; Fujinaga K
Genes Chromosomes Cancer; 1996 Feb; 15(2):115-21. PubMed ID: 8834175
[TBL] [Abstract][Full Text] [Related]
50. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
Deuel TF; Guan LS; Wang ZY
Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
[TBL] [Abstract][Full Text] [Related]
51. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
52. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator.
Labelle Y; Bussières J; Courjal F; Goldring MB
Oncogene; 1999 May; 18(21):3303-8. PubMed ID: 10359536
[TBL] [Abstract][Full Text] [Related]
53. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun.
Dejong V; Degeorges A; Filleur S; Ait-Si-Ali S; Mettouchi A; Bornstein P; Binétruy B; Cabon F
Oncogene; 1999 May; 18(20):3143-51. PubMed ID: 10340386
[TBL] [Abstract][Full Text] [Related]
54. The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.
Bandopadhayay P; Jabbour AM; Riffkin C; Salmanidis M; Gordon L; Popovski D; Rigby L; Ashley DM; Watkins DN; Thomas DM; Algar E; Ekert PG
BMC Cancer; 2013 Dec; 13():585. PubMed ID: 24321497
[TBL] [Abstract][Full Text] [Related]
55. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line.
McMaster ML; Gessler M; Stanbridge EJ; Weissman BE
Cell Growth Differ; 1995 Dec; 6(12):1609-17. PubMed ID: 9019166
[TBL] [Abstract][Full Text] [Related]
56. Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.
Sjögren H; Meis-Kindblom J; Kindblom LG; Aman P; Stenman G
Cancer Res; 1999 Oct; 59(20):5064-7. PubMed ID: 10537274
[TBL] [Abstract][Full Text] [Related]
57. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.
Brown AD; Lopez-Terrada D; Denny C; Lee KA
Oncogene; 1995 May; 10(9):1749-56. PubMed ID: 7753552
[TBL] [Abstract][Full Text] [Related]
58. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.
Teitell MA; Thompson AD; Sorensen PH; Shimada H; Triche TJ; Denny CT
Lab Invest; 1999 Dec; 79(12):1535-43. PubMed ID: 10616204
[TBL] [Abstract][Full Text] [Related]
59. WT1 splicing alterations in Wilms' tumors.
Baudry D; Hamelin M; Cabanis MO; Fournet JC; Tournade MF; Sarnacki S; Junien C; Jeanpierre C
Clin Cancer Res; 2000 Oct; 6(10):3957-65. PubMed ID: 11051244
[TBL] [Abstract][Full Text] [Related]
60. A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease.
Ferreira EN; Barros BD; de Souza JE; Almeida RV; Torrezan GT; Garcia S; Krepischi AC; Mello CA; Cunha IW; Pinto CA; Soares FA; Dias-Neto E; Lopes A; de Souza SJ; Carraro DM
Hum Genomics; 2016 Nov; 10(1):36. PubMed ID: 27863505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
